301 related articles for article (PubMed ID: 18632985)
1. HDAC4 promotes growth of colon cancer cells via repression of p21.
Wilson AJ; Byun DS; Nasser S; Murray LB; Ayyanar K; Arango D; Figueroa M; Melnick A; Kao GD; Augenlicht LH; Mariadason JM
Mol Biol Cell; 2008 Oct; 19(10):4062-75. PubMed ID: 18632985
[TBL] [Abstract][Full Text] [Related]
2. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
Mottet D; Pirotte S; Lamour V; Hagedorn M; Javerzat S; Bikfalvi A; Bellahcène A; Verdin E; Castronovo V
Oncogene; 2009 Jan; 28(2):243-56. PubMed ID: 18850004
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer.
Wilson AJ; Byun DS; Popova N; Murray LB; L'Italien K; Sowa Y; Arango D; Velcich A; Augenlicht LH; Mariadason JM
J Biol Chem; 2006 May; 281(19):13548-13558. PubMed ID: 16533812
[TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.
Yuan JH; Yang F; Chen BF; Lu Z; Huo XS; Zhou WP; Wang F; Sun SH
Hepatology; 2011 Dec; 54(6):2025-35. PubMed ID: 21837748
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase HDAC4 promotes gastric cancer SGC-7901 cells progression via p21 repression.
Kang ZH; Wang CY; Zhang WL; Zhang JT; Yuan CH; Zhao PW; Lin YY; Hong S; Li CY; Wang L
PLoS One; 2014; 9(6):e98894. PubMed ID: 24896240
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 4 increases progressive epithelial ovarian cancer cells via repression of p21 on fibrillar collagen matrices.
Shen YF; Wei AM; Kou Q; Zhu QY; Zhang L
Oncol Rep; 2016 Feb; 35(2):948-54. PubMed ID: 26572940
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of histone deacetylase 4, -5 and -6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin.
Oya Y; Mondal A; Rawangkan A; Umsumarng S; Iida K; Watanabe T; Kanno M; Suzuki K; Li Z; Kagechika H; Shudo K; Fujiki H; Suganuma M
J Nutr Biochem; 2017 Apr; 42():7-16. PubMed ID: 28103535
[TBL] [Abstract][Full Text] [Related]
9. HDAC4 protein regulates HIF1α protein lysine acetylation and cancer cell response to hypoxia.
Geng H; Harvey CT; Pittsenbarger J; Liu Q; Beer TM; Xue C; Qian DZ
J Biol Chem; 2011 Nov; 286(44):38095-38102. PubMed ID: 21917920
[TBL] [Abstract][Full Text] [Related]
10. Regulation of histone deacetylase 4 expression by the SP family of transcription factors.
Liu F; Pore N; Kim M; Voong KR; Dowling M; Maity A; Kao GD
Mol Biol Cell; 2006 Feb; 17(2):585-97. PubMed ID: 16280357
[TBL] [Abstract][Full Text] [Related]
11. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis.
Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R
J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600
[TBL] [Abstract][Full Text] [Related]
12. ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line.
Varshochi R; Halim F; Sunters A; Alao JP; Madureira PA; Hart SM; Ali S; Vigushin DM; Coombes RC; Lam EW
J Biol Chem; 2005 Feb; 280(5):3185-96. PubMed ID: 15557281
[TBL] [Abstract][Full Text] [Related]
13. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus.
Liu R; Wang L; Chen G; Katoh H; Chen C; Liu Y; Zheng P
Cancer Res; 2009 Mar; 69(6):2252-9. PubMed ID: 19276356
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
[TBL] [Abstract][Full Text] [Related]
15. Disruption of HDAC4/N-CoR complex by histone deacetylase inhibitors leads to inhibition of IL-2 gene expression.
Matsuoka H; Fujimura T; Hayashi M; Matsuda K; Ishii Y; Aramori I; Mutoh S
Biochem Pharmacol; 2007 Aug; 74(3):465-76. PubMed ID: 17559812
[TBL] [Abstract][Full Text] [Related]
16. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing.
Ahn MY; Kang DO; Na YJ; Yoon S; Choi WS; Kang KW; Chung HY; Jung JH; Min do S; Kim HS
Cancer Lett; 2012 Dec; 325(2):189-99. PubMed ID: 22781396
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
Duan H; Heckman CA; Boxer LM
Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
[TBL] [Abstract][Full Text] [Related]
19. PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21.
Gong FR; Wu MY; Shen M; Zhi Q; Xu ZK; Wang R; Wang WJ; Zong Y; Li ZL; Wu Y; Zhou BP; Chen K; Tao M; Li W
Oncotarget; 2015 Jul; 6(21):18469-83. PubMed ID: 26053095
[TBL] [Abstract][Full Text] [Related]
20. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
